SGOL2 | shugoshin-like 2 (S. pombe) | 2q33.2 | 0.321 | -0.302 | 2.19e-10
|
SMC2 | structural maintenance of chromosomes 2 | 9q31.1 | 0.317 | -0.445 | 0
|
LUC7L | LUC7-like | 16p13.3 | 0.316 | 0.434 | 0
|
RRM1 | ribonucleotide reductase M1 | 11p15.5 | 0.315 | -0.433 | 0
|
RAD21 | RAD21 cohesin complex component | 8q24.11 | 0.312 | -0.332 | 2.7e-12
|
RHOT2 | ras homolog family member T2 | 16p13.3 | 0.312 | 0.38 | 2.43e-16
|
CCNL2 | cyclin L2 | 1p36.33 | 0.312 | 0.392 | 0
|
ARMC1 | armadillo repeat containing 1 | 8q12.3 | 0.311 | -0.389 | 0
|
LMBR1L | limb development membrane protein 1-like | 12q13.12 | 0.309 | 0.535 | 0
|
GMPS | guanine monophosphate synthase | 3q25.31 | 0.307 | -0.4 | 0
|
AGER | advanced glycosylation end product-specific receptor | 6p21.3 | 0.307 | 0.491 | 0
|
CHEK1 | checkpoint kinase 1 | 11q24.2 | 0.304 | -0.343 | 4.19e-13
|
CLTC | clathrin, heavy chain (Hc) | 17q23.1 | 0.302 | -0.389 | 0
|
TAF1C | TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 110kDa | 16q24 | 0.3 | 0.43 | 0
|
FCHSD1 | FCH and double SH3 domains 1 | 5q31.3 | 0.3 | 0.41 | 0
|
TMEM86B | transmembrane protein 86B | 19q13.42 | 0.3 | 0.443 | 0
|
TRIM37 | tripartite motif containing 37 | 17q | 0.299 | -0.381 | 2.07e-16
|
PRIM1 | primase, DNA, polypeptide 1 (49kDa) | 12q13.3 | 0.299 | -0.271 | 1.48e-08
|
ANKRD13D | ankyrin repeat domain 13 family, member D | 11q13.2 | 0.298 | 0.422 | 0
|
XPOT | exportin, tRNA | 12q14.1 | 0.298 | -0.308 | 9.29e-11
|
BARD1 | BRCA1 associated RING domain 1 | 2q35 | 0.297 | -0.343 | 3.94e-13
|
TTC37 | tetratricopeptide repeat domain 37 | 5q15 | 0.296 | -0.24 | 5.74e-07
|
MZF1 | myeloid zinc finger 1 | 19q13.43 | 0.296 | 0.357 | 3.68e-14
|
PRKDC | protein kinase, DNA-activated, catalytic polypeptide | 8q11 | 0.295 | -0.372 | 1.76e-15
|
UBAP1L | ubiquitin associated protein 1-like | 15q22.31 | 0.294 | 0.414 | 0
|
ARRDC2 | arrestin domain containing 2 | 19p13.12 | 0.293 | 0.431 | 0
|
TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 | 1p36.32 | 0.293 | 0.422 | 0
|
LINC01089 | long intergenic non-protein coding RNA 1089 | 12q24.31 | 0.293 | 0.38 | 2.75e-16
|
PPP1R12C | protein phosphatase 1, regulatory subunit 12C | 19q13.42 | 0.292 | 0.431 | 0
|
GPATCH11 | G patch domain containing 11 | 2p22.2 | 0.292 | -0.362 | 1.59e-14
|
UBXN7 | UBX domain protein 7 | 3q29 | 0.291 | -0.358 | 3.03e-14
|
HEXDC | hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing | 17q25.3 | 0.291 | 0.395 | 0
|
L2HGDH | L-2-hydroxyglutarate dehydrogenase | 14q22.1 | 0.291 | -0.389 | 0
|
PLS3 | plastin 3 | Xq23 | 0.289 | -0.326 | 6.85e-12
|
RNF20 | ring finger protein 20, E3 ubiquitin protein ligase | 9q22 | 0.287 | -0.362 | 1.34e-14
|
DHX36 | DEAH (Asp-Glu-Ala-His) box polypeptide 36 | 3q25.2 | 0.287 | -0.33 | 3.79e-12
|
NLN | neurolysin (metallopeptidase M3 family) | 5q12.3 | 0.287 | -0.38 | 2.12e-16
|
NPFF | neuropeptide FF-amide peptide precursor | 12q13.13 | 0.286 | 0.412 | 0
|
MAPK8IP3 | mitogen-activated protein kinase 8 interacting protein 3 | 16p13.3 | 0.286 | 0.413 | 0
|
RGL2 | ral guanine nucleotide dissociation stimulator-like 2 | 6p21.3 | 0.285 | 0.359 | 2.8e-14
|
CERS6 | ceramide synthase 6 | 2q31 | 0.284 | -0.388 | 0
|
PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 12p13.31 | 0.284 | 0.423 | 0
|
WDHD1 | WD repeat and HMG-box DNA binding protein 1 | 14q22.2 | 0.283 | -0.381 | 1.71e-16
|
PPP1R2P3 | protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 3 | 5q33.3 | 0.283 | -0.415 | 0
|
FSD1L | fibronectin type III and SPRY domain containing 1-like | 9q31 | 0.283 | -0.39 | 0
|
PRIM2 | primase, DNA, polypeptide 2 (58kDa) | 6p12-p11.1 | 0.282 | -0.37 | 3.19e-15
|
LRRC58 | leucine rich repeat containing 58 | 3q13.33 | 0.282 | -0.333 | 2.04e-12
|
ACAT1 | acetyl-CoA acetyltransferase 1 | 11q22.3 | 0.282 | -0.324 | 8.31e-12
|
AGAP3 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 | 7q36.1 | 0.282 | 0.386 | 1.01e-17
|
TRIOBP | TRIO and F-actin binding protein | 22q13.1 | 0.282 | 0.358 | 3.18e-14
|
PLCD3 | phospholipase C, delta 3 | 17q21 | 0.282 | 0.346 | 2.36e-13
|
TIAF1 | TGFB1-induced anti-apoptotic factor 1 | 17q11.2 | 0.282 | 0.326 | 6.39e-12
|
FAM212A | family with sequence similarity 212, member A | 3p21.31 | 0.281 | 0.296 | 5.55e-10
|
NCAPD3 | non-SMC condensin II complex, subunit D3 | 11q25 | 0.281 | -0.329 | 4.17e-12
|
KIAA1958 | KIAA1958 | 9q33.1 | 0.28 | -0.359 | 2.35e-14
|
RC3H2 | ring finger and CCCH-type domains 2 | 9q34 | 0.28 | -0.363 | 1.21e-14
|
ZW10 | zw10 kinetochore protein | 11q23 | 0.28 | -0.338 | 1.03e-12
|
PPP6C | protein phosphatase 6, catalytic subunit | 9q33.3 | 0.278 | -0.363 | 1.12e-14
|
RNF138 | ring finger protein 138, E3 ubiquitin protein ligase | 18q12.1 | 0.278 | -0.301 | 2.56e-10
|
SRC | SRC proto-oncogene, non-receptor tyrosine kinase | 20q12-q13 | 0.278 | 0.352 | 9.81e-14
|
CEP128 | centrosomal protein 128kDa | 14q31.1 | 0.278 | -0.334 | 1.95e-12
|
GMFG | glia maturation factor, gamma | 19q13.2 | 0.278 | 0.319 | 1.85e-11
|
OSBPL11 | oxysterol binding protein-like 11 | 3q21 | 0.277 | -0.379 | 3.38e-16
|
BTBD16 | BTB (POZ) domain containing 16 | 10q26.13 | 0.277 | 0.291 | 1.02e-09
|
RAB40A | RAB40A, member RAS oncogene family | Xq22.1 | 0.277 | 0.322 | 1.29e-11
|
LZTS2 | leucine zipper, putative tumor suppressor 2 | 10q24 | 0.277 | 0.334 | 1.83e-12
|
STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 12q13 | 0.277 | 0.342 | 4.72e-13
|
DGKA | diacylglycerol kinase, alpha 80kDa | 12q13.3 | 0.276 | 0.29 | 1.16e-09
|
ARAP3 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 | 5q31.3 | 0.276 | 0.311 | 6.51e-11
|
CLDN15 | claudin 15 | 7q22 | 0.276 | 0.311 | 6.14e-11
|
DOK7 | docking protein 7 | 4p16.2 | 0.276 | 0.412 | 0
|
TMEM51 | transmembrane protein 51 | 1p36.21 | 0.274 | 0.352 | 9.81e-14
|
CTDSP1 | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 | 2q35 | 0.274 | 0.361 | 1.82e-14
|
LRPPRC | leucine-rich pentatricopeptide repeat containing | 2p21 | 0.274 | -0.314 | 3.87e-11
|
ZNF276 | zinc finger protein 276 | 16q24.3 | 0.274 | 0.379 | 3.52e-16
|
OTX1 | orthodenticle homeobox 1 | 2p15 | 0.274 | -0.274 | 9.35e-09
|
RSRC1 | arginine/serine-rich coiled-coil 1 | 3q25.32 | 0.273 | -0.381 | 2.06e-16
|
CLK1 | CDC-like kinase 1 | 2q33 | 0.273 | 0.25 | 1.75e-07
|
SH2D3A | SH2 domain containing 3A | 19p13.3 | 0.272 | 0.326 | 6.35e-12
|
CAPN15 | calpain 15 | 16p13.3 | 0.271 | 0.371 | 2.21e-15
|
PYROXD2 | pyridine nucleotide-disulphide oxidoreductase domain 2 | 10q24.2 | 0.271 | 0.308 | 1.02e-10
|
EPHB6 | EPH receptor B6 | 7q33-q35 | 0.27 | 0.386 | 1.35e-17
|
MBTPS2 | membrane-bound transcription factor peptidase, site 2 | Xp22.12-p22.11 | 0.27 | -0.305 | 1.6e-10
|
KRT7 | keratin 7, type II | 12q13.13 | 0.269 | 0.349 | 1.44e-13
|
VKORC1L1 | vitamin K epoxide reductase complex, subunit 1-like 1 | 7q11.21 | 0.268 | -0.317 | 2.52e-11
|
YME1L1 | YME1-like 1 ATPase | 10p14 | 0.268 | -0.459 | 0
|
ISCA1P1 | iron-sulfur cluster assembly 1 pseudogene 1 | 5q12.1 | 0.268 | -0.361 | 1.89e-14
|
BATF | basic leucine zipper transcription factor, ATF-like | 14q24 | 0.268 | 0.348 | 1.71e-13
|
PLA2G2F | phospholipase A2, group IIF | 1p35 | 0.267 | 0.29 | 1.2e-09
|
SPOCD1 | SPOC domain containing 1 | 1p35.1 | 0.267 | 0.359 | 2.74e-14
|
PEX26 | peroxisomal biogenesis factor 26 | 22q11.21 | 0.267 | -0.246 | 2.9e-07
|
PGM3 | phosphoglucomutase 3 | 6q14.1-q15 | 0.267 | -0.337 | 1.07e-12
|
RHBDF1 | rhomboid 5 homolog 1 (Drosophila) | 16p13.3 | 0.266 | 0.308 | 9.35e-11
|
C7orf43 | chromosome 7 open reading frame 43 | 7q22.1 | 0.266 | 0.338 | 9.03e-13
|
ELMOD3 | ELMO/CED-12 domain containing 3 | 2p11.2 | 0.266 | 0.404 | 0
|
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 12p12.3 | 0.265 | 0.302 | 2.39e-10
|
UCHL5 | ubiquitin carboxyl-terminal hydrolase L5 | 1q32 | 0.265 | -0.408 | 0
|
RNPEPL1 | arginyl aminopeptidase (aminopeptidase B)-like 1 | 2q37.3 | 0.265 | 0.343 | 4.06e-13
|
ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | 3q13.31 | 0.264 | -0.38 | 2.64e-16
|
ITPKC | inositol-trisphosphate 3-kinase C | 19q13.1 | 0.263 | 0.172 | 0.000363
|
SSR3 | signal sequence receptor, gamma (translocon-associated protein gamma) | 3q25.31 | 0.263 | -0.345 | 2.97e-13
|
RAPGEF3 | Rap guanine nucleotide exchange factor (GEF) 3 | 12q13.1 | 0.262 | 0.412 | 0
|
SH3BGRL3 | SH3 domain binding glutamate-rich protein like 3 | 1p36.11 | 0.262 | 0.27 | 1.56e-08
|
MOB3C | MOB kinase activator 3C | 1p34.1 | 0.262 | 0.393 | 0
|
FBXL8 | F-box and leucine-rich repeat protein 8 | 16q22.1-q22.3 | 0.261 | 0.304 | 1.71e-10
|
PPM1N | protein phosphatase, Mg2+/Mn2+ dependent, 1N (putative) | 19q13.32 | 0.26 | 0.375 | 1.06e-15
|
TRIM8 | tripartite motif containing 8 | 10q24.3 | 0.26 | 0.402 | 0
|
ZRANB3 | zinc finger, RAN-binding domain containing 3 | 2q21.3 | 0.26 | -0.361 | 1.88e-14
|
RBM44 | RNA binding motif protein 44 | 2q37.3 | 0.26 | 0.343 | 4.17e-13
|
COPB2 | coatomer protein complex, subunit beta 2 (beta prime) | 3q23 | 0.259 | -0.282 | 3.37e-09
|
ARAP1 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 | 11q13.3 | 0.259 | 0.408 | 0
|
FXR1 | fragile X mental retardation, autosomal homolog 1 | 3q28 | 0.259 | -0.384 | 4.65e-17
|
APBB3 | amyloid beta (A4) precursor protein-binding, family B, member 3 | 5q31 | 0.259 | 0.277 | 6.42e-09
|
OGFR | opioid growth factor receptor | 20q13.3 | 0.258 | 0.343 | 4.46e-13
|
RBM5 | RNA binding motif protein 5 | 3p21.3 | 0.258 | 0.29 | 1.18e-09
|
MATR3 | matrin 3 | 5q31.3 | 0.256 | -0.274 | 1.04e-08
|
VASP | vasodilator-stimulated phosphoprotein | 19q13.32 | 0.256 | 0.368 | 4.47e-15
|
MICALL2 | MICAL-like 2 | 7p22.3 | 0.256 | 0.31 | 7.53e-11
|
LRMP | lymphoid-restricted membrane protein | 12p12.1 | 0.255 | 0.223 | 3.48e-06
|
LRRC15 | leucine rich repeat containing 15 | 3q29 | 0.255 | -0.077 | 0.112
|
FGD5 | FYVE, RhoGEF and PH domain containing 5 | 3p25.1 | 0.252 | 0.304 | 1.73e-10
|
UBA7 | ubiquitin-like modifier activating enzyme 7 | 3p21 | 0.251 | 0.354 | 6.84e-14
|
DGKQ | diacylglycerol kinase, theta 110kDa | 4p16.3 | 0.249 | 0.356 | 4.38e-14
|
TRIP10 | thyroid hormone receptor interactor 10 | 19p13.3 | 0.248 | 0.314 | 3.82e-11
|
TSC2 | tuberous sclerosis 2 | 16p13.3 | 0.248 | 0.284 | 2.59e-09
|
POLM | polymerase (DNA directed), mu | 7p13 | 0.248 | 0.335 | 1.59e-12
|
PHF11 | PHD finger protein 11 | 13q14.11 | 0.248 | 0.34 | 6.46e-13
|
PCED1B | PC-esterase domain containing 1B | 12q13.11 | 0.247 | 0.37 | 2.89e-15
|
DERL1 | derlin 1 | 8q24.13 | 0.247 | -0.264 | 3.31e-08
|
DARS2 | aspartyl-tRNA synthetase 2, mitochondrial | 1q25.1 | 0.247 | -0.36 | 2.11e-14
|
PIP5K1C | phosphatidylinositol-4-phosphate 5-kinase, type I, gamma | 19p13.3 | 0.247 | 0.337 | 1.14e-12
|
FLYWCH1 | FLYWCH-type zinc finger 1 | 16p13.3 | 0.246 | 0.255 | 9.73e-08
|
C15orf52 | chromosome 15 open reading frame 52 | 15q15.1 | 0.245 | 0.345 | 2.94e-13
|
PSD4 | pleckstrin and Sec7 domain containing 4 | 2q13 | 0.245 | 0.284 | 2.85e-09
|
DYM | dymeclin | 18q21.1 | 0.243 | -0.369 | 3.78e-15
|
REXO1 | REX1, RNA exonuclease 1 homolog | 19p13.3 | 0.243 | 0.331 | 2.91e-12
|
PHF1 | PHD finger protein 1 | 6p21.3 | 0.242 | 0.294 | 7.03e-10
|
HLTF | helicase-like transcription factor | 3q25.1-q26.1 | 0.242 | -0.289 | 1.32e-09
|
GPR63 | G protein-coupled receptor 63 | 6q16.1-q16.3 | 0.241 | -0.248 | 2.33e-07
|
ACLY | ATP citrate lyase | 17q21.2 | 0.241 | -0.311 | 6.01e-11
|
GPR78 | G protein-coupled receptor 78 | 4p16.1 | 0.241 | 0.247 | 2.55e-07
|
PPP6R1 | protein phosphatase 6, regulatory subunit 1 | 19q13.42 | 0.241 | 0.326 | 7e-12
|
ZBTB7A | zinc finger and BTB domain containing 7A | 19p13.3 | 0.24 | 0.216 | 7.09e-06
|
MAP3K11 | mitogen-activated protein kinase kinase kinase 11 | 11q13.1-q13.3 | 0.24 | 0.31 | 7.51e-11
|
CSNK1E | casein kinase 1, epsilon | 22q13.1 | 0.239 | 0.293 | 8.41e-10
|
TMEM8A | transmembrane protein 8A | 16p13.3 | 0.239 | 0.314 | 3.95e-11
|
IL4R | interleukin 4 receptor | 16p12.1-p11.2 | 0.239 | 0.214 | 8.52e-06
|
FAM109A | family with sequence similarity 109, member A | 12q24.12 | 0.237 | 0.401 | 0
|
CATSPER1 | cation channel, sperm associated 1 | 11q12.1 | 0.237 | 0.351 | 1.05e-13
|
PXN | paxillin | 12q24 | 0.237 | 0.394 | 0
|
TERF1 | telomeric repeat binding factor (NIMA-interacting) 1 | 8q21.11 | 0.236 | -0.307 | 1.09e-10
|
PIAS2 | protein inhibitor of activated STAT, 2 | 18q12.1-q12.3 | 0.236 | -0.356 | 4.77e-14
|
CCDC112 | coiled-coil domain containing 112 | 5q22.3 | 0.235 | -0.251 | 1.7e-07
|
NR6A1 | nuclear receptor subfamily 6, group A, member 1 | 9q33.3 | 0.233 | -0.266 | 2.67e-08
|
SLC48A1 | solute carrier family 48 (heme transporter), member 1 | 12q13.11 | 0.233 | 0.36 | 2.28e-14
|
LCAT | lecithin-cholesterol acyltransferase | 16q22.1 | 0.233 | 0.348 | 1.67e-13
|
HSFX2 | heat shock transcription factor family, X-linked 2 | Xq28 | 0.232 | 0.374 | 1.2e-15
|
HNRNPLL | heterogeneous nuclear ribonucleoprotein L-like | 2p22 | 0.231 | -0.202 | 2.75e-05
|
CTH | cystathionine gamma-lyase | 1p31.1 | 0.23 | -0.316 | 3.05e-11
|
RGMA | repulsive guidance molecule family member a | 15q26.1 | 0.23 | -0.215 | 7.79e-06
|
HSPA14 | heat shock 70kDa protein 14 | 10p13 | 0.229 | -0.325 | 7.15e-12
|
GFER | growth factor, augmenter of liver regeneration | 16p13.3-p13.12 | 0.229 | 0.261 | 5e-08
|
IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 1q32.1 | 0.228 | 0.254 | 1.15e-07
|
ST6GALNAC1 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | 17q25.3 | 0.228 | 0.013 | 0.79
|
MAFK | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K | 7p22 | 0.228 | 0.24 | 5.73e-07
|
RLIM | ring finger protein, LIM domain interacting | Xq13-q21 | 0.227 | -0.196 | 4.9e-05
|
MTDH | metadherin | 8q22.1 | 0.226 | -0.276 | 7.38e-09
|
URGCP | upregulator of cell proliferation | 7p13 | 0.226 | 0.294 | 7.13e-10
|
GDAP1 | ganglioside induced differentiation associated protein 1 | 8q13.3 | 0.226 | -0.272 | 1.3e-08
|
NCKAP5L | NCK-associated protein 5-like | 12q13.12 | 0.225 | 0.394 | 0
|
MLF1 | myeloid leukemia factor 1 | 3q25 | 0.225 | -0.306 | 1.24e-10
|
UCA1 | urothelial cancer associated 1 (non-protein coding) | 19p13.12 | 0.225 | 0.234 | 1.08e-06
|
PCSK9 | proprotein convertase subtilisin/kexin type 9 | 1p32.3 | 0.224 | -0.285 | 2.5e-09
|
GALM | galactose mutarotase (aldose 1-epimerase) | 2p22.3 | 0.224 | 0.112 | 0.021
|
TNNI2 | troponin I type 2 (skeletal, fast) | 11p15.5 | 0.223 | 0.287 | 1.73e-09
|
AFG3L2 | AFG3-like AAA ATPase 2 | 18p11.21 | 0.223 | -0.362 | 1.55e-14
|
NKIRAS1 | NFKB inhibitor interacting Ras-like 1 | 3p24.1 | 0.223 | -0.308 | 9.14e-11
|
RHOBTB2 | Rho-related BTB domain containing 2 | 8p21.2 | 0.223 | 0.257 | 8.45e-08
|
PMM2 | phosphomannomutase 2 | 16p13 | 0.222 | 0.138 | 0.00444
|
SLC8B1 | solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 | 12q24.13 | 0.222 | 0.42 | 0
|
APOBR | apolipoprotein B receptor | 16p11.2 | 0.222 | 0.23 | 1.75e-06
|
SHISA5 | shisa family member 5 | 3p21.31 | 0.221 | 0.204 | 2.28e-05
|
LRRC16B | leucine rich repeat containing 16B | 14q11.2-q12 | 0.221 | 0.022 | 0.65
|
CLEC18A | C-type lectin domain family 18, member A | 16q22.1 | 0.221 | 0.246 | 2.95e-07
|
CCDC43 | coiled-coil domain containing 43 | 17q21.31 | 0.221 | -0.295 | 6.24e-10
|
LZIC | leucine zipper and CTNNBIP1 domain containing | 1p36.22 | 0.22 | -0.294 | 6.73e-10
|
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | 2q24 | 0.22 | 0.114 | 0.0189
|
ARL6 | ADP-ribosylation factor-like 6 | 3q11.2 | 0.22 | -0.195 | 5.23e-05
|
C1QTNF6 | C1q and tumor necrosis factor related protein 6 | 22q13.1 | 0.22 | 0.108 | 0.0251
|
SLC25A34 | solute carrier family 25, member 34 | 1p36.13 | 0.219 | 0.285 | 2.24e-09
|
DAB2IP | DAB2 interacting protein | 9q33.1-q33.3 | 0.218 | 0.177 | 0.000251
|
BCAR1 | breast cancer anti-estrogen resistance 1 | 16q23.1 | 0.216 | 0.242 | 4.59e-07
|
GLIS2 | GLIS family zinc finger 2 | 16p13.3 | 0.215 | 0.077 | 0.114
|
ADAM8 | ADAM metallopeptidase domain 8 | 10q26.3 | 0.214 | 0.249 | 2.02e-07
|
MKL1 | megakaryoblastic leukemia (translocation) 1 | 22q13 | 0.213 | 0.271 | 1.51e-08
|
DGKD | diacylglycerol kinase, delta 130kDa | 2q37 | 0.213 | 0.327 | 5.67e-12
|
ITGB6 | integrin, beta 6 | 2q24.2 | 0.212 | 0.192 | 6.63e-05
|
LACTB2 | lactamase, beta 2 | 8q13.3 | 0.211 | -0.323 | 1.12e-11
|
ALPP | alkaline phosphatase, placental | 2q37.1 | 0.211 | 0.004 | 0.936
|
PTK2B | protein tyrosine kinase 2 beta | 8p21.1 | 0.211 | 0.225 | 2.79e-06
|
SPRYD3 | SPRY domain containing 3 | 12q13.13 | 0.211 | 0.235 | 1.01e-06
|
MED30 | mediator complex subunit 30 | 8q24.11 | 0.21 | -0.203 | 2.47e-05
|
TET1 | tet methylcytosine dioxygenase 1 | 10q21 | 0.209 | -0.278 | 6.31e-09
|
RAB43 | RAB43, member RAS oncogene family | 3q21.3 | 0.209 | 0.078 | 0.106
|
CCL17 | chemokine (C-C motif) ligand 17 | 16q13 | 0.208 | 0.283 | 2.98e-09
|
TFRC | transferrin receptor | 3q29 | 0.207 | -0.269 | 1.84e-08
|
GPR35 | G protein-coupled receptor 35 | 2q37.3 | 0.207 | 0.237 | 8.26e-07
|
COX11 | COX11 cytochrome c oxidase copper chaperone | 17q22 | 0.207 | -0.241 | 4.89e-07
|
TMEFF1 | transmembrane protein with EGF-like and two follistatin-like domains 1 | 9q31 | 0.206 | -0.237 | 8.03e-07
|
DIAPH2 | diaphanous-related formin 2 | Xq22 | 0.206 | -0.309 | 8.69e-11
|
MDFI | MyoD family inhibitor | 6p21 | 0.205 | 0.338 | 9.54e-13
|
PCCB | propionyl CoA carboxylase, beta polypeptide | 3q21-q22 | 0.205 | -0.185 | 0.000127
|
H6PD | hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) | 1p36 | 0.205 | 0.159 | 0.00101
|
ENOPH1 | enolase-phosphatase 1 | 4q21.3 | 0.205 | -0.213 | 9.03e-06
|
RTN2 | reticulon 2 | 19q13.2-q13.3 | 0.204 | 0.261 | 5.25e-08
|
CCR3 | chemokine (C-C motif) receptor 3 | 3p21.3 | 0.203 | 0.057 | 0.238
|
XBP1 | X-box binding protein 1 | 22q12.1 | 0.203 | -0.056 | 0.249
|
MKNK1 | MAP kinase interacting serine/threonine kinase 1 | 1p33 | 0.203 | 0.266 | 2.79e-08
|
EMC2 | ER membrane protein complex subunit 2 | 8q23.2 | 0.202 | -0.319 | 2.02e-11
|
SEMA4C | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C | 2q11.2 | 0.198 | 0.259 | 6.05e-08
|
CHST4 | carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4 | 16q22.2 | 0.198 | -0.075 | 0.124
|
HRASLS | HRAS-like suppressor | 3q29 | 0.198 | -0.198 | 4.05e-05
|
ABHD6 | abhydrolase domain containing 6 | 3p21.2 | 0.197 | -0.127 | 0.00878
|
CLCN5 | chloride channel, voltage-sensitive 5 | Xp11.23-p11.22 | 0.195 | -0.123 | 0.0111
|
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 1q21 | 0.195 | 0.19 | 8.05e-05
|
RIMKLA | ribosomal modification protein rimK-like family member A | 1p34.2 | 0.194 | -0.006 | 0.904
|
MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 22q13.33 | 0.191 | -0.251 | 1.66e-07
|
STK31 | serine/threonine kinase 31 | 7p15.3 | 0.191 | 0.062 | 0.203
|
PPP1R9B | protein phosphatase 1, regulatory subunit 9B | 17q21.33 | 0.191 | 0.279 | 5.44e-09
|
TIMM21 | translocase of inner mitochondrial membrane 21 homolog (yeast) | 18q22.3 | 0.19 | -0.248 | 2.39e-07
|
DUSP5P1 | dual specificity phosphatase 5 pseudogene 1 | 1q42.13 | 0.186 | -0.268 | 2.22e-08
|
FBLIM1 | filamin binding LIM protein 1 | 1p36.13 | 0.183 | 0.147 | 0.00229
|
FAM171B | family with sequence similarity 171, member B | 2q32.2 | 0.177 | -0.194 | 5.41e-05
|
DCAF6 | DDB1 and CUL4 associated factor 6 | 1q23.3 | 0.177 | -0.264 | 3.37e-08
|
SQSTM1 | sequestosome 1 | 5q35 | 0.175 | 0.003 | 0.946
|